BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 07/08/2013

Purdue Pharma L.P. Withdraws Approval of Oxycontin NDA

The FDA is withdrawing approval of a new drug application for Oxycontin, a medication made by Purdue Pharma L.P., after the company voluntarily requested the withdrawal and waived its right to a hearing.

Source: Federal Register — Food and Drug AdministrationOpen original release →